Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta

Watson Pharmaceuticals, Inc. Tuesday announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to market the authorized generic version of Concerta (methylphenidate hydrochloride extended-release tablets).
Forbes